InsiderTrades.com logo

OBIO Insider Trading

Insider Ownership Percentage: 8.10%
Insider Buying (Last 12 Months): $109,845.00
Insider Selling (Last 12 Months): $138,572.97

Orchestra BioMed Insider Trading History Chart

This chart shows the insider buying and selling history at Orchestra BioMed by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Orchestra BioMed Share Price & Price History

Current Price: $2.73
Price Change: ▼ Price Decrease of -0.01 (-0.36%)
As of 05/22/2025 05:00 PM ET

This chart shows the closing price history over time for OBIO up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Orchestra BioMed Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/23/2024David P HochmanInsiderBuy4,000$4.66$18,640.00579,498View SEC Filing Icon  
12/19/2024Andrew Lawrence TaylorCFOBuy1,000$4.83$4,830.00344,960View SEC Filing Icon  
12/18/2024David P HochmanInsiderBuy5,000$4.91$24,550.00575,498View SEC Filing Icon  
9/24/2024David P HochmanInsiderBuy2,500$4.91$12,275.00570,498View SEC Filing Icon  
9/9/2024Darren ShermanInsiderSell6,804$5.48$37,285.92772,691View SEC Filing Icon  
9/9/2024Eric S FainDirectorSell1,800$5.43$9,774.0043,010View SEC Filing Icon  
9/6/2024Darren ShermanInsiderSell6,819$5.65$38,527.35779,495View SEC Filing Icon  
9/6/2024Eric S FainDirectorSell2,000$5.64$11,280.0044,810View SEC Filing Icon  
9/4/2024Darren ShermanInsiderSell6,837$6.10$41,705.70793,275View SEC Filing Icon  
8/14/2024David P HochmanInsiderBuy2,500$5.84$14,600.00567,998View SEC Filing Icon  
6/25/2024David P HochmanInsiderBuy1,000$6.95$6,950.00333,502View SEC Filing Icon  
5/30/2024William Reed LittleInsiderBuy4,000$7.00$28,000.00307,859View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Orchestra BioMed (NASDAQ:OBIO)

53.55% of Orchestra BioMed stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at OBIO by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Orchestra BioMed Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/16/2025Goldman Sachs Group Inc.48,729$0.21M0.0%-21.6%0.127%Search for SEC Filing on Google Icon
5/13/2025HighTower Advisors LLC61,000$0.26M0.0%-10.9%0.159%Search for SEC Filing on Google Icon
5/12/2025Nuveen LLC41,729$0.18M0.0%N/A0.109%Search for SEC Filing on Google Icon
5/9/2025Deutsche Bank AG20,219$87K0.0%+67.3%0.053%Search for SEC Filing on Google Icon
5/5/2025IFP Advisors Inc161,921$0.69M0.0%+106.4%0.423%Search for SEC Filing on Google Icon
2/17/2025Millennium Management LLC21,513$86K0.0%N/A0.057%Search for SEC Filing on Google Icon
2/17/2025Citadel Advisors LLC12,279$49K0.0%-39.0%0.032%Search for SEC Filing on Google Icon
2/17/2025Bank of America Corp DE23,780$95K0.0%+42.0%0.063%Search for SEC Filing on Google Icon
2/14/2025Boxer Capital Management LLC238,193$0.95M0.1%N/A0.627%Search for SEC Filing on Google Icon
2/14/2025Northern Trust Corp236,761$0.95M0.0%+2.5%0.623%Search for SEC Filing on Google Icon
2/14/2025The Manufacturers Life Insurance Company37,009$0.15M0.0%+11.1%0.097%Search for SEC Filing on Google Icon
2/14/2025Price T Rowe Associates Inc. MD487,170$1.95M0.0%-5.0%1.282%Search for SEC Filing on Google Icon
2/13/2025Barclays PLC37,786$0.15M0.0%+18.9%0.099%Search for SEC Filing on Google Icon
2/13/2025Wells Fargo & Company MN13,156$53K0.0%+43.6%0.035%Search for SEC Filing on Google Icon
2/12/2025Geode Capital Management LLC572,441$2.29M0.0%+0.9%1.506%Search for SEC Filing on Google Icon
2/12/2025JPMorgan Chase & Co.49,405$0.20M0.0%+354.5%0.130%Search for SEC Filing on Google Icon
2/7/2025HighTower Advisors LLC68,500$0.27M0.0%+34.3%0.180%Search for SEC Filing on Google Icon
1/17/2025SG Americas Securities LLC12,785$51K0.0%+26.0%0.034%Search for SEC Filing on Google Icon
11/21/2024SkyView Investment Advisors LLC12,284$63K0.0%-38.6%0.032%Search for SEC Filing on Google Icon
11/19/2024Barclays PLC31,785$0.16M0.0%+281.3%0.084%Search for SEC Filing on Google Icon
11/16/2024Geode Capital Management LLC567,219$2.92M0.0%+2.0%1.492%Search for SEC Filing on Google Icon
11/15/2024Barclays PLC31,785$0.16M0.0%+281.3%0.084%Search for SEC Filing on Google Icon
11/15/2024Jane Street Group LLC19,070$98K0.0%-19.8%0.050%Search for SEC Filing on Google Icon
11/15/2024State Street Corp429,613$2.21M0.0%+12.4%1.130%Search for SEC Filing on Google Icon
11/15/2024RTW Investments LP8,206,159$42.18M0.6%+46.0%21.587%Search for SEC Filing on Google Icon
11/13/2024The Manufacturers Life Insurance Company33,305$0.17M0.0%-20.9%0.088%Search for SEC Filing on Google Icon
11/12/2024Charles Schwab Investment Management Inc.217,008$1.12M0.0%+3.9%0.574%Search for SEC Filing on Google Icon
11/1/2024ABLE Financial Group LLC13,402$69K0.0%N/A0.035%Search for SEC Filing on Google Icon
10/3/2024SG Americas Securities LLC10,143$52K0.0%N/A0.028%Search for SEC Filing on Google Icon
8/16/2024SkyView Investment Advisors LLC20,000$0.16M0.0%N/A0.056%Search for SEC Filing on Google Icon
8/15/2024The Manufacturers Life Insurance Company42,082$0.34M0.0%+8.4%0.118%Search for SEC Filing on Google Icon
8/1/2024Rhumbline Advisers26,439$0.22M0.0%+192.7%0.074%Search for SEC Filing on Google Icon
7/26/2024Bank of New York Mellon Corp70,682$0.58M0.0%+115.7%0.197%Search for SEC Filing on Google Icon
5/15/2024Price T Rowe Associates Inc. MD571,075$3.01M0.0%-8.3%1.596%Search for SEC Filing on Google Icon
5/11/2024Catalytic Wealth RIA LLC22,261$0.12M0.0%N/A0.062%Search for SEC Filing on Google Icon
2/1/2024New York State Common Retirement Fund3,623$33K0.0%-68.6%0.010%Search for SEC Filing on Google Icon
10/27/2023Allspring Global Investments Holdings LLC4,904$43K0.0%N/A0.014%Search for SEC Filing on Google Icon
10/27/2023TD Asset Management Inc92,678$0.81M0.0%+100.0%0.259%Search for SEC Filing on Google Icon
10/24/2023Bank of New York Mellon Corp40,290$0.35M0.0%+211.2%0.113%Search for SEC Filing on Google Icon
10/18/2023UMB Bank n.a.3,160$28K0.0%N/A0.009%Search for SEC Filing on Google Icon
10/13/2023Arkadios Wealth Advisors51,595$0.45M0.0%N/A0.144%Search for SEC Filing on Google Icon
8/24/2023Perceptive Advisors LLC2,052,868$14.37M0.4%-9.9%5.744%Search for SEC Filing on Google Icon
8/11/2023Atika Capital Management LLC64,651$0.45M0.0%N/A0.181%Search for SEC Filing on Google Icon
5/16/2023Boxer Capital LLC250,000$4.89M0.2%N/A2.230%Search for SEC Filing on Google Icon
5/15/2023RTW Investments LP5,118,507$100.17M2.1%N/A45.652%Search for SEC Filing on Google Icon
4/18/2023IFP Advisors Inc2,980$34K0.0%N/A0.027%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Orchestra BioMed logo
Orchestra BioMed Holdings, Inc. operates as a biomedical innovation company. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension (HTN); and Virtue Sirolimus AngioInfusion Balloon (SAB) for the treatment of atherosclerotic artery disease. Its products also comprise FreeHold devices and minimally invasive surgery devices. The company has a collaboration agreement with Medtronic, Inc. for the development and commercialization of BackBeat CNT for the treatment of HTN in patients indicated for a cardiac pacemaker; and a strategic collaboration with Terumo Medical Corporation for the development and commercialization of Virtue SAB for the treatment of coronary and peripheral artery disease. Orchestra BioMed Holdings, Inc. is based in New Hope, Pennsylvania.
Read More on Orchestra BioMed

Today's Range

Now: $2.73
Low: $2.70
High: $2.80

50 Day Range

MA: $3.16
Low: $2.42
High: $4.60

52 Week Range

Now: $2.73
Low: $2.37
High: $8.87

Volume

76,705 shs

Average Volume

164,089 shs

Market Capitalization

$104.59 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.67

Who are the company insiders with the largest holdings of Orchestra BioMed?

Orchestra BioMed's top insider investors include:
  1. Darren Sherman (Insider)
  2. David P Hochman (Insider)
  3. Andrew Lawrence Taylor (CFO)
  4. William Reed Little (Insider)
  5. Eric S Fain (Director)
Learn More about top insider investors at Orchestra BioMed.

Who are the major institutional investors of Orchestra BioMed?

Orchestra BioMed's top institutional investors include:
  1. IFP Advisors Inc — 0.42%
  2. HighTower Advisors LLC — 0.16%
  3. Goldman Sachs Group Inc. — 0.13%
  4. Nuveen LLC — 0.11%
  5. Deutsche Bank AG — 0.05%
Learn More about top institutional investors of Orchestra BioMed stock.

Which major investors are selling Orchestra BioMed stock?

During the previous quarter, OBIO stock was sold by these institutional investors:
  1. Goldman Sachs Group Inc.
  2. HighTower Advisors LLC
Within the previous year, company insiders that have sold Orchestra BioMed company stock include:
  1. Darren Sherman (Insider)
  2. David P Hochman (Insider)
Learn More investors selling Orchestra BioMed stock.

Which major investors are buying Orchestra BioMed stock?

In the previous quarter, OBIO stock was bought by institutional investors including:
  1. IFP Advisors Inc
  2. Nuveen LLC
  3. Deutsche Bank AG
In the last year, these company insiders have bought Orchestra BioMed stock:
  1. Darren Sherman (Insider)
  2. David P Hochman (Insider)
  3. Andrew Lawrence Taylor (CFO)
Learn More investors buying Orchestra BioMed stock.